PUBLICATION
Chemical Week
Australia Chemicals 2006 IHS CW Release
September 13, 2006
To most of our readers, Australia is known as the country of kangaroos. Few of those involved in the chemical trade know that Australia boasts a chemical industry with a structure, products and strategies as particular as its fauna. As the industry finds itself in the endgame of transforming from import-substitution to providing high-value added chemicals and services, it looks back on two decades of change – and a challenging future ahead. Reasons enough to have a look at the continent’s rich chemical past, present and future.
RELATED INTERVIEWS MORE INTERVIEWS
Haldor Topsoe discusses the potential for energy transition in Latin America.
The Mexican Union of Agrochemicals Manufacturers and Formulators (UMFFAAC) describes the main themes impacting its members.
"Preparing the industry to seize the opportunity is crucial. Just as the US experienced stages during the shale boom, Argentina must follow similar steps."
Cristian García of PROCCYT explains the dynamics influencing Mexico’s crop protecting sector.
RELATED ARTICLES MORE ARTICLES
Solid Demand Factors but Political Risk Rising
Mexico Petrochemicals and Chemicals 2018 APLA Pre-Release
Rising exports and a growing middle class bode well for Mexico’s chemical demand, but NAFTA renegotiations, Presidential elections and the slow pace of energy reforms are present concerns.
Chemical Distribution in Latin America
Latin America Petrochemicals and Chemicals 2024 - Digital Interactive
There is still room for consolidation
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
MORE PREVIOUSLY PUBLISHED
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
MORE PREVIOUSLY PUBLISHED
MACIG
"We are in a dysfunctional supply-demand balance and the price will bounce back, probably around 2028; the year when Atlantic Lithium should start production."
SUBSCRIBE TO OUR NEWSLETTER
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
